This recommendation follows the list of 5 released last year by the organization, with the aim of helping the patient and physician choose appropriate treatments.
The Choosing Wisely campaign, initiated by the American Board of Internal Medicine, aims at questioning procedures that may be redundant and in need of a revamp. The American Society for Radiation Oncology (ASTRO) released it's second set of 5 treatments used in radiation oncology that may not always be appropriate. The list includes the following recommendations:
1. Don't recommend radiation following hysterectomy for endometrial cancer patients with low-risk disease.
2. Don't routinely offer radiation therapy for patients who have resected non-small cell lung cancer, negative margins, N0-1 disease.
3. Don't initiate non-curative radiation therapy without defining the goals of treatment with the patient and considering palliative care referral.
4. Don't routinely recommend follow-up mammograms more than annually for women who have had radiotherapy following breast conserving therapy.
5. Don't routinely add adjuvant whole brain radiation therapy to stereotactic radiosurgery for limited brain metastases.
These guidelines were developed by a committee that included individuals working in health policy, government relations, and clinical affairs and quality. The team developed a survey that was then mailed out to ASTRO's members, to rate 28 potential topics that could be addressed. Eight of the top 9 items were then selected and sent to ASTRO's board of directors to create a final list of 5.
Detailed release: http://bit.ly/1qQfHbt
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy
December 16th 2025The foundation of medically integrated pharmacy includes 7 critical pillars. This commentary focuses on the benefits of 3 of those pillars: abandonment, adherence, and access/affordability.
Read More